Sign In
Buy HOLX
$76.01
+0 (+0%)
At Close: Jun 03, 2026
A Preview Of Hologic's Earnings
10:47am, Friday, 29'th Oct 2021
Hologic (NASDAQ:HOLX) is set to give its latest quarterly earnings report on Monday, 2021-11-01. Here's what investors need to know before the announcement.
Hologic (HOLX) to Report Q4 Earnings: What's in the Cards?
11:52am, Tuesday, 26'th Oct 2021
Hologic's (HOLX) recent acquisitions and product launches are expected to contribute significantly to its fourth-quarter performance.
Hologic (HOLX) Stock Sinks As Market Gains: What You Should Know
07:15pm, Monday, 25'th Oct 2021
Hologic (HOLX) closed the most recent trading day at $73.03, moving -0.79% from the previous trading session.
Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know
10:17pm, Monday, 18'th Oct 2021
Hologic (HOLX) closed at $70.02 in the latest trading session, marking a +0.5% move from the prior day.
Hologic to Acquire Bolder Surgical for $160 Million, Expanding its Surgical Franchise
04:02pm, Thursday, 14'th Oct 2021
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #HOLX--Hologic to Acquire Bolder Surgical for $160 Million, Expanding its Surgical Franchise
Hologic (HOLX) Launches Novodiag System for On-Demand Testing
01:24pm, Tuesday, 12'th Oct 2021
Hologic (HOLX) introduces the Novodiag system in Europe for on-demand testing of infectious diseases and antimicrobial resistance.
Hologic (HOLX) Dips More Than Broader Markets: What You Should Know
07:58pm, Monday, 11'th Oct 2021
In the latest trading session, Hologic (HOLX) closed at $69.95, marking a -1.99% move from the previous day.
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2021 on Monday, November 1, 2021
04:05pm, Thursday, 07'th Oct 2021
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #HOLX--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2021 on Monday, November 1, 2021
Hologic Launches Novodiag® System for On-Demand Molecular Testing in Europe
03:00am, Tuesday, 05'th Oct 2021
MANCHESTER, England--(BUSINESS WIRE)--Hologic Launches Novodiag® System for On-Demand Molecular Testing in Europe
Hologic CEO Steve MacMillan on the impact of the Covid pandemic on women's cancer screenings
07:10am, Monday, 04'th Oct 2021
Steve MacMillan, President and CEO of Hologic, joins Worldwide Exchange to discuss the company's recent Global Women's Health Index, and how the Covid pandemic has impacted the state of women's health
Hologic Rings Nasdaq Opening Bell for 15th Time to Kick Off Breast Cancer Awareness Month
06:00am, Monday, 04'th Oct 2021
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #BCAM--Hologic Rings Nasdaq Opening Bell for 15th Time to Kick Off Breast Cancer Awareness Month
Hologic (HOLX) Adds New Products to Omni Hysteroscopy Offering
11:42am, Friday, 01'st Oct 2021
Hologic (HOLX) expands Omni suite in EMEA with the new Omni 30 degree hysteroscope, Omni Lok cervical seal and Omni 5 French seal products.
Hologic Expands its Omni® Hysteroscopy Offering in Europe
08:00am, Thursday, 30'th Sep 2021
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Expands its Omni® Hysteroscopy Offering in Europe
Hologic (HOLX) Stock Moves -1.57%: What You Should Know
07:21pm, Tuesday, 28'th Sep 2021
Hologic (HOLX) closed at $72.87 in the latest trading session, marking a -1.57% move from the prior day.
Hologic: An Undervalued Leader
08:12pm, Wednesday, 22'nd Sep 2021
Hologic: An Undervalued Leader
